Abstract

BackgroundBone mineral density (BMD) detected by dual energy x-ray absorptiometry (DXA) is a gold standard and powerful predictor of osteoporotic fractures. BMD in patients with psoriatic arthritis (PsA) can be...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly.
Marco Losa ... Andrea Giustina
The Journal of clinical endocrinology and metabolism | VOL. 107
Marco Losa, et. al.Marco Losa ... Andrea Giustina
29 Mar 2022
Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis.
Xiaohong Sun ... Jun Jiang
Clinical rheumatology | VOL. 41
Xiaohong Sun, et. al.Xiaohong Sun ... Jun Jiang
10 Jan 2022
Analysis of factors related to osteoporotic vertebral fracture in prostate cancer patients
Jianjun Zhou ... Shuting Lin
Discover Oncology | VOL. 15
Jianjun Zhou, et. al.Jianjun Zhou ... Shuting Lin
13 Feb 2024
The Prevalence of Undetected Vertebral Fracture in Patients with Back Pain by Dual-Energy X-ray Absorptiometry (DXA) of the Lateral Thoracic and Lumbar Spine.
Morteza Bahri Iraee ... Hadi Akhbari
Asian spine journal | VOL. 5
Morteza Bahri Iraee, et. al.Morteza Bahri Iraee ... Hadi Akhbari
01 Jan 2010
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers